[1]
Sharma, R.; Kr Sharma, H. A review on plants having anti-cancer activity. Pharm. Res., 2017, 4(2), 39-62.
[3]
Amirah, A. Preventive role of amygdalin in squamous cell carcinoma induced in hamsters. Int. J. Pharm. Sci. Med., 2017, 2, 8-14.
[6]
Hye Min, L.; Moon, A. Amygdalin regulates apoptosis and adhesion in Hs578T triple-negative breast cancer cells. Korean Soc. Appl. Pharmacol., 2016, 24(1), 62-66.
[7]
Mosadegh, M.S.; Safavi, M.; Rostami, S.; Nadali, F.; Shams, A.M.R. Apoptosis induction of armeniacae semen extractin human acute leukemia (NALM-6 and KG-1) cells. Int. J. Hematol. stem cell Res., 2019, 13(3), 116-121.
[14]
Dorris, J. Hutchison Schmid, F. A. OBITUARIES-Kanematsu Sugiura 1890-1979. Cancer Res., 1980, 40, 2625-2626.
[25]
Manhardt, M.A. Correlation of injected amygdalin and urinary thiocyanate in JAX C57 BL/KsJ mice. Master’s Thesis, Loyola University, Chicago, 1981.
[32]
Oyewole, O.I.; Olayinka, E.T. Hydroxocobalamin (Vit b 12a) effectively reduced extent of cyanide poisoning arising from oral amygdalin ingestion in rats. J. Toxicol. Environ. Heal. Sci., 2009, 1(1), 8-11.
[33]
Enculescu, M. Vitamin B 17/Laetrile/Amygdalin (a review). Bull. Univ. Agric. Sci. Vet. Med. Cluj-Napoca Anim. Sci. Biotechnol., 2009, 66(11), 20-25.
[42]
Iib, S.; Values, B. A. T. Benzaldehyde 1984.
[44]
Rowe, A.V. The non-teratogenic effects in mice progeny by maternal treatment with amygdalin recommended citation. Master’s Thesis, Loyola University, Chicago, 1978.
[47]
Shalayel, M.H.F. Beyond laetrile (Vitamin B-17) controversy-antitumor illusion or revolution. Br. Biomed. Bull., 2017, 5(1), 296.
[48]
The Cancer Group Institute, In: Complementary and Natural
Treatments for Bladder Cancer It’s Your Life, Live It!; Beverly
Hills: California, 2011, 328.
[52]
Cheah, P-L.; Frcpath, M. p53: An overview of over two decades of study. Malays. J. Pathol., 2001, 23(1), 9-16.
[58]
Robles, A.I.; Bemmels, N.A.; Foraker, A.B.; Harris, C.C. APAF-1 is a transcriptional target of p53 in dna damage-induced apoptosis. Cancer Res., 2001, 61(18), 6660-6664.